WHO ICTRP trial
Combining contrast enhanced mammography and radio-active free magnetic seed…
NL-OMON56142 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON56142 |
|---|---|
| Public title | Combining contrast enhanced mammography and radio-active free magnetic seed localization of non-palpable breast tumors: A feasibility study |
| Scientific title | Combining contrast enhanced mammography and radio-active free magnetic seed localization of non-palpable breast tumors: A feasibility study - CEMMAG |
| Primary sponsor | Zuyderland Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Countries | Netherlands |
| Conditions | breast cancer breast tumor;10006291;10006295;breast cancer;breast tumor |
| Interventions | ;Breast neoplasms;Localisation;Mammography |
| Registration date | Oct 31, 2023 |
| Target size | 20 |
| Secondary IDs | NL83090.096.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: